scholarly journals Predicting 5-fluorouracil chemosensitivity of liver metastases from colorectal cancer using primary tumor specimens: Three-gene expression model predicts clinical response

2006 ◽  
Vol 119 (2) ◽  
pp. 406-413 ◽  
Author(s):  
Ryusei Matsuyama ◽  
Shinji Togo ◽  
Daisuke Shimizu ◽  
Nobuyoshi Momiyama ◽  
Takashi Ishikawa ◽  
...  
Cancers ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 2148
Author(s):  
Francesco Ardito ◽  
Francesco Razionale ◽  
Lisa Salvatore ◽  
Tonia Cenci ◽  
Maria Vellone ◽  
...  

If KRAS mutation status of primary colorectal tumor is representative of corresponding colorectal liver metastases (CRLM) mutational pattern, is controversial. Several studies have reported different rates of KRAS discordance, ranging from 4 to 32%. Aim of this study is to assess the incidence of discordance and its impact on overall survival (OS) in a homogenous group of patients. KRAS mutation status was evaluated in 107 patients resected for both primary colorectal tumor and corresponding CRLM at the same institution, between 2007 and 2018. Discordance rate was 15.9%. Its incidence varied according to the time interval between the two mutation analyses (p = 0.025; Pearson correlation = 0.2) and it was significantly higher during the first 6 months from the time of primary tumor evaluation. On multivariable analysis, type of discordance (wild-type in primary tumor, mutation in CRLM) was the strongest predictor of poor OS (p < 0.001). At multivariable logistic regression analysis, the number of CRLM >3 was an independent risk factor for the risk of KRAS discordance associated with the worst prognosis (OR = 4.600; p = 0.047). Results of our study suggested that, in the era of precision medicine, possibility of KRAS discordance should be taken into account within multidisciplinary management of patients with metastatic colorectal cancer.


BIOMAT 2011 ◽  
2012 ◽  
pp. 153-177
Author(s):  
N. A. BARBOSA ◽  
H DÍAZ ◽  
A. RAMIREZ

Genes ◽  
2021 ◽  
Vol 12 (10) ◽  
pp. 1531
Author(s):  
Vânia Tavares ◽  
Joana Monteiro ◽  
Evangelos Vassos ◽  
Jonathan Coleman ◽  
Diana Prata

Predicting gene expression from genotyped data is valuable for studying inaccessible tissues such as the brain. Herein we present eGenScore, a polygenic/poly-variation method, and compare it with PrediXcan, a method based on regularized linear regression using elastic nets. While both methods have the same purpose of predicting gene expression based on genotype, they carry important methodological differences. We compared the performance of expression quantitative trait loci (eQTL) models to predict gene expression in the frontal cortex, comparing across these frameworks (eGenScore vs. PrediXcan) and training datasets (BrainEAC, which is brain-specific, vs. GTEx, which has data across multiple tissues). In addition to internal five-fold cross-validation, we externally validated the gene expression models using the CommonMind Consortium database. Our results showed that (1) PrediXcan outperforms eGenScore regardless of the training database used; and (2) when using PrediXcan, the performance of the eQTL models in frontal cortex is higher when trained with GTEx than with BrainEAC.


2020 ◽  
Vol 106 (5) ◽  
pp. 1132-1133
Author(s):  
D. Adkins ◽  
J. Ley ◽  
N. LaFranzo ◽  
J. Hiken ◽  
I. Schillebeeckx ◽  
...  

2019 ◽  
Vol 9 (10) ◽  
Author(s):  
Marco Bolis ◽  
Mineko Terao ◽  
Linda Pattini ◽  
Enrico Garattini ◽  
Maddalena Fratelli

2020 ◽  
Vol 122 (4) ◽  
pp. 745-752
Author(s):  
Katherine Bingmer ◽  
Asya Ofshteyn ◽  
Jonathan T. Bliggenstorfer ◽  
William Kethman ◽  
John B. Ammori ◽  
...  

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 15062-15062
Author(s):  
M. A. Pantaleo ◽  
A. Astolfi ◽  
M. Nannini ◽  
P. Paterini ◽  
G. Piazzi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document